These shared mechanisms of colon cancer and CIPN pathophysiology suggest MMP9’s potential contribution to neuropathic conditions in CRC patients, positioning it as a critical factor in disease progression and a promising therapeutic target. Here, MMP9 is linked to malignant colon neoplasm.